您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股招股说明书]:安费诺美股招股说明书(2025-06-09版) - 发现报告

安费诺美股招股说明书(2025-06-09版)

2025-06-09 美股招股说明书 申明华
报告封面

AMPHENOL CORPORATION % Senior Notes due 20 We are offering $aggregate principal amount of our% Senior Notes due 20(the “notes”).We will pay interest on the notes semi-annually onandof each year, beginning on The notes will be our unsecured senior obligations and will rank equally in right of payment with all of our otherunsecured senior indebtedness outstanding from time to time. We may redeem some or all of the notes from time to time at the applicable redemption prices described in “Descriptionof the Notes — Optional Redemption” in this prospectus supplement. Unless we have previously redeemed the notes, if a Change of Control Repurchase Event (as defined herein) occurs, wewill be required to offer to repurchase the notes at a purchase price in cash equal to 101% of the principal amount of the notes,plus any accrued and unpaid interest to, but not including, the date of repurchase as described under “Description of the Notes Substantially concurrently with or shortly after this offering, we expect to offer, by means of a separate prospectussupplement, approximately €aggregate principal amount of euro-denominated senior notes (the “Euro Notes”).Neither the completion of this offering nor the offering of the Euro Notes (the “Euro Notes Offering”) is contingent on thecompletion of the other, so it is possible that this offering occurs and the Euro Notes Offering does not occur, and vice versa.We cannot assure you that the Euro Notes Offering will be completed on the terms described herein, or at all. This prospectussupplement is not an offer to sell or a solicitation of an offer to buy any Euro Notes being offered in the Euro Notes Offering. Investing in the notes involves risks. See “Risk Factors” beginning on pageS-10of this prospectus supplement and on page5of the accompanying prospectus and the risk factors included in our periodic reports filed with the Securities and ExchangeCommission under the Securities Exchange Act of 1934, as amended, each of which is incorporated by reference herein, for adiscussion of certain risks you should consider carefully before investing in the notes. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representationto the contrary is a criminal offense. Per noteTotal Each of this prospectus supplement, the accompanying prospectus and any free writing prospectus weauthorize contains and incorporates by reference information that you should consider when making yourinvestment decision. We have not, and the underwriters have not, authorized anyone to provide you with You should assume that the information contained in this prospectus supplement, the accompanyingprospectus, any free writing prospectus and the documents incorporated by reference herein and therein, is We are not, and the underwriters are not, making an offer to sell the notes in any jurisdiction where theoffer or sale is not permitted. ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement supplements the accompanying prospectus. The accompanying prospectusis part of an automatic shelf registration statement on Form S-3 that we filed with the Securities andExchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”),using a “shelf” registration, or continuous offering, process. Under this shelf registration process, we may,at any time and from time to time, issue and sell, in one or more offerings, the senior debt securities, The accompanying prospectus provides you with a general description of the senior debt securities, andthis prospectus supplement contains specific information about the terms of this offering of the notes. Thisprospectus supplement, or the information incorporated by reference in this prospectus supplement or theaccompanying prospectus, may add, update or change information contained in the accompanyingprospectus. If information in this prospectus supplement, or the information incorporated by reference in Before making your investment decision, you should read and carefully consider this prospectussupplement and the accompanying prospectus, together with the additional information in the documents Unless otherwise stated, or the context otherwise requires, references in this prospectus supplement to“we,” “us,” “our,” “Amphenol,” “APH” and “the Company” are to Amphenol Corporation and, asapplicable, its consolidated subsidiaries, except for purposes of the description of the notes included in thisprospectus supplement and the accompanying prospectus, where references to such terms refer only to FORWARD-LOOKING STATEMENTS This prospectus supplement, the accompanying prospectus and the documents incorporated byreference herein and therein, include forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995 an